WALTHAM, Mass., Feb. 19, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report fourth quarter and fiscal year-end 2008 results, along with guidance for 2009, on Thursday, February 26, 2009 . A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EST (1:30 p.m. PST).
